NCT05868889View on ClinicalTrials.gov

Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

June 10, 2022

Study Completion Date

June 16, 2022

Conditions
Ovarian Cancer
Interventions
DRUG

Trabectedin and PLD

The main treatment observed in this study is trabectedin in combination with PLD in elderly patients with platinum-sensitive relapsed ovarian cancer, according to the SmPC.

Trial Locations (1)

14004

Hospital Universitario Reina Sofía, Córdoba

All Listed Sponsors
lead

Grupo Español de Investigación en Cáncer de Ovario

OTHER

NCT05868889 - Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD | Biotech Hunter | Biotech Hunter